Evaluation of von Willebrand factor-cleaving protease activity in patients with thrombotic thrombocytopenic purpura

Chinese Medical Journal

Volumn 117, Issue 6, 2004, Pages 818-822

  Gao, Wei Qiang ^a   Su, Jian ^a   Bai, Xia ^a   Wang, Zhao Yue ^a   Ruan, Chang Geng ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Cleaving protease; Collagen binding assay; Thrombotic thrombocytopenic purpura; Tumor; von Willebrand factor

Indexed keywords

COLLAGEN; POLYCLONAL ANTIBODY; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ANEMIA; ARTICLE; BLOOD SAMPLING; BRAIN TUMOR; BREAST FIBROADENOMA; CLINICAL FEATURE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MYOMA; PANCREAS CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOPLASMS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 3242679719     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-1584.
2. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-1594.
3. Zheng X, Chung D, Takayama TK, et al. Structure of von Willebrand factor cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 2001;276:41059-41063.
4. Oleksowicz L, Bhagwati N, DeLeon-Fernandez, et al. Dificient activity of von Willebrand's factor-cleaving protease in patients with disseminated malignancies. Cancer Res 1999;59:2244-2250.
5. Mannucci PM, Karimi M, Mosalaei A, et al. Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS13 (von Willebrand factor cleaving protease). Haematologica 2003;88:454-458.
6. Xi X, Ruan C, Li P, et al. Use of monoclonal antibodies in enzyme-linked immunoassay for von Willebrand factor. Chin J Med Lab Sci 1988;11:272-275.
7. Rick M, Moll S, Taylor M, et al. Clinical use of a rapid collagen binding assay for von Willebrand factor cleaving protease in patients with thrombotic thrombocytopenic purpura. Thromb Haemost 2002;88:598-604.
8. Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VII/von Willebrand factor. Blood 1981; 57:1140-1143.
9. Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001;413:488-494.
10. Moake JL. Thrombotic microangiopathies. N Eng J Med 2002;347:589-600.
11. Ruggeri ZM. Old concepts and new developments in the study of platelet aggregation. J Clin Invest 2000;105:699-701.
12. Studt JD, Böhm M, Budde U, et al. Measurement of von Willebrand factor-cleaving protease (ADAMTS13) activity in plasma: a multicenter comparison of different assay methods. J Thromb Haemost 2003;1:1882-1887.
13. Furlan M, Lammle B. Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura. Semin Thromb Hemost 2002;28:167-172.
14. Barbot J, Costa E, Guerra M, et al. Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease. Br J Haematol 2001;113:649-651.
15. Tsai HM. High titers of inhibitors of von Willebrand factor-cleaving metalloproteinase in a fatal case of acute thrombotic thrombocytopenic purpura. Am J Hematol 2000;65:251-255.
16. Rock G, Porta C, Bobbio-Pallavicini E, et al. Thrombotic thrombocytopenic purpura treatment in year 2000. Haematologica 2000;85:410-419.
17. Blot E, Decaudin D, Veyradier A, et al. Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency. Thromb Res 2002;106: 127-130.